Literature DB >> 11824566

Reconsideration of drug release from temperature-sensitive liposomes.

Atsuo Ono1, Kentaro Takeuchi, Akemi Sukenari, Tomoaki Suzuki, Isao Adachi, Masaharu Ueno.   

Abstract

The liposomal phase transition temperature was monitored in unstirred suspensions using a differential scanning calorimeter. The main and pre-transition temperatures under conditions of stirring were measured by the change in 90 degrees light scattering using a fluorescence spectrophotometer. Both methods show the same main transition temperature either with or without stirring. Temperature sensitive liposomes were made of DPPC (dipalmitoylphosphatidylcholine), DMPC (dimylisitoylphosphatidylcholine) or DSPC (distearoylphosphatidylcholine). The calcein release profile from the liposomes depends on the stirring time of the liposome suspension at the main transition temperature. For 1 h incubation, the leakage profile with and without stirring is similar. It had been hypothesized that temperature sensitive liposomes released drug at the main-transition temperature. However, calcein leakage from liposomes is observed also at the pre-transition temperature. Thus, a liposomal encapsulated drug will likely leak from DPPC liposomes at body temperature (37 degrees C), even if the liposomes were designed to have a higher main transition temperature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824566     DOI: 10.1248/bpb.25.97

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling.

Authors:  Andrei Ponta; Kyle D Fugit; Bradley D Anderson; Younsoo Bae
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

2.  New ways of imaging uptake and intracellular fate of liposomal drug carrier systems inside individual cells, based on Raman microscopy.

Authors:  Christian Matthäus; Amit Kale; Tatyana Chernenko; Vladimir Torchilin; Max Diem
Journal:  Mol Pharm       Date:  2008-01-16       Impact factor: 4.939

3.  Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma.

Authors:  Hongyan Zhu; Weili Han; Ye Gan; Qiaofeng Li; Xiaolan Li; Lanlan Shao; Dan Zhu; Hongwei Guo
Journal:  Pharmaceutics       Date:  2019-12-15       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.